Andrew T Grainger1, Michael B Jones2, Jing Li2, Mei-Hua Chen2, Ani Manichaikul3, Weibin Shi4. 1. Department of Biochemistry & Molecular Genetics, University of Virginia, Charlottesville, VA, USA. 2. Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. 3. Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA. 4. Department of Biochemistry & Molecular Genetics, University of Virginia, Charlottesville, VA, USA; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. Electronic address: ws4v@virginia.edu.
Abstract
BACKGROUND AND AIMS: Recent genome-wide association studies (GWAS) have identified over 50 significant loci containing common variants associated with coronary artery disease. However, these variants explain only 26% of the genetic heritability of the disease, suggesting that many more variants remain to be discovered. Here, we examined the genetic basis underlying the marked difference between SM/J-Apoe-/- and BALB/cJ-Apoe-/- mice in atherosclerotic lesion formation. METHODS: 206 female F2 mice generated from an intercross between the two Apoe-/- strains were fed 12 weeks of western diet. Atherosclerotic lesion sizes in the aortic root were measured and 149 genetic markers genotyped across the entire genome. RESULTS: A significant locus, named Ath49 (LOD score: 4.18), for atherosclerosis was mapped to the H2 complex [mouse major histocompatibility complex (MHC)] on chromosome 17. Bioinformatic analysis identified 12 probable candidate genes, including Tnfrsf21, Adgrf1, Adgrf5, Mep1a, and Pla2g7. Corresponding human genomic regions of Ath49 showed significant association with coronary heart disease. Five suggestive loci on chromosomes 1, 4, 5, and 8 for atherosclerosis were also identified. Atherosclerotic lesion sizes were significantly correlated with HDL but not with non-HDL cholesterol, triglyceride or glucose levels in the F2 cohort. CONCLUSIONS: We have identified the MHC as a major genetic determinant of atherosclerosis, highlighting the importance of inflammation in atherogenesis.
BACKGROUND AND AIMS: Recent genome-wide association studies (GWAS) have identified over 50 significant loci containing common variants associated with coronary artery disease. However, these variants explain only 26% of the genetic heritability of the disease, suggesting that many more variants remain to be discovered. Here, we examined the genetic basis underlying the marked difference between SM/J-Apoe-/- and BALB/cJ-Apoe-/- mice in atherosclerotic lesion formation. METHODS: 206 female F2 mice generated from an intercross between the two Apoe-/- strains were fed 12 weeks of western diet. Atherosclerotic lesion sizes in the aortic root were measured and 149 genetic markers genotyped across the entire genome. RESULTS: A significant locus, named Ath49 (LOD score: 4.18), for atherosclerosis was mapped to the H2 complex [mouse major histocompatibility complex (MHC)] on chromosome 17. Bioinformatic analysis identified 12 probable candidate genes, including Tnfrsf21, Adgrf1, Adgrf5, Mep1a, and Pla2g7. Corresponding human genomic regions of Ath49 showed significant association with coronary heart disease. Five suggestive loci on chromosomes 1, 4, 5, and 8 for atherosclerosis were also identified. Atherosclerotic lesion sizes were significantly correlated with HDL but not with non-HDL cholesterol, triglyceride or glucose levels in the F2 cohort. CONCLUSIONS: We have identified the MHC as a major genetic determinant of atherosclerosis, highlighting the importance of inflammation in atherogenesis.
Authors: C L Welch; S Bretschger; N Latib; M Bezouevski; Y Guo; N Pleskac; C P Liang; C Barlow; H Dansky; J L Breslow; A R Tall Journal: Proc Natl Acad Sci U S A Date: 2001-07-03 Impact factor: 11.205
Authors: Oduola Abiola; Joe M Angel; Philip Avner; Alexander A Bachmanov; John K Belknap; Beth Bennett; Elizabeth P Blankenhorn; David A Blizard; Valerie Bolivar; Gundrun A Brockmann; Kari J Buck; Jean-Francoise Bureau; William L Casley; Elissa J Chesler; James M Cheverud; Gary A Churchill; Melloni Cook; John C Crabbe; Wim E Crusio; Ariel Darvasi; Gerald de Haan; Peter Dermant; R W Doerge; Rosemary W Elliot; Charles R Farber; Lorraine Flaherty; Jonathan Flint; Howard Gershenfeld; John P Gibson; Jing Gu; Weikuan Gu; Heinz Himmelbauer; Robert Hitzemann; Hui-Chen Hsu; Kent Hunter; Fuad F Iraqi; Ritsert C Jansen; Thomas E Johnson; Byron C Jones; Gerd Kempermann; Frank Lammert; Lu Lu; Kenneth F Manly; Douglas B Matthews; Juan F Medrano; Margarete Mehrabian; Guy Mittlemann; Beverly A Mock; Jeffrey S Mogil; Xavier Montagutelli; Grant Morahan; John D Mountz; Hiroki Nagase; Richard S Nowakowski; Bruce F O'Hara; Alexander V Osadchuk; Beverly Paigen; Abraham A Palmer; Jeremy L Peirce; Daniel Pomp; Michael Rosemann; Glenn D Rosen; Leonard C Schalkwyk; Ze'ev Seltzer; Stephen Settle; Kazuhiro Shimomura; Siming Shou; James M Sikela; Linda D Siracusa; Jimmy L Spearow; Cory Teuscher; David W Threadgill; Linda A Toth; Ayo A Toye; Csaba Vadasz; Gary Van Zant; Edward Wakeland; Robert W Williams; Huang-Ge Zhang; Fei Zou Journal: Nat Rev Genet Date: 2003-11 Impact factor: 53.242
Authors: Zhiguang Su; Yuhua Li; Jessica C James; Marcia McDuffie; Alan H Matsumoto; Gregory A Helm; James L Weber; Aldons J Lusis; Weibin Shi Journal: Genetics Date: 2005-12-30 Impact factor: 4.562
Authors: Hayes M Dansky; Pei Shu; M Donavan; Jill Montagno; Deborah L Nagle; John S Smutko; Natalie Roy; S Whiteing; Judith Barrios; T J McBride; Jonathan D Smith; Geoffrey Duyk; Jan L Breslow; Karen J Moore Journal: Genetics Date: 2002-04 Impact factor: 4.562
Authors: Andrew T Grainger; Nathanael Pilar; Jun Li; Mei-Hua Chen; Ashley M Abramson; Christoph Becker-Pauly; Weibin Shi Journal: Genetics Date: 2021-12-10 Impact factor: 4.402